Cutaneous granulomas with primary immunodeficiency in children: a report of 17 new patients and a review of the literature.


Journal

Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 17 08 2018
accepted: 29 01 2019
pubmed: 15 3 2019
medline: 16 1 2020
entrez: 15 3 2019
Statut: ppublish

Résumé

Paediatric cutaneous granuloma with primary immunodeficiency (PID) is a rare condition. The physiopathology is unclear, and treatment is challenging. We report on 17 paediatric cases and review the literature. To make dermatologists and dermatopathologists aware of the diagnostic value of skin granulomas in paediatric PID. We collected data on 17 patients with cutaneous granulomas and PID registered with us and also reviewed 33 cases from the literature. Cutaneous granuloma was the presenting feature of the PID in 15 of the 50 collated cases. The lesions presented as red-brownish nodules and infiltrated ulcerative plaques, predominantly on the face and limbs. Scleroderma-like infiltration on a single limb was observed in 10% of the cases. The associated PID was ataxia-telangiectasia (52%), combined immunodeficiency (24%), cartilage-hair hypoplasia (6%) and other subtypes (18%). The granulomas were mostly sarcoidal, tuberculoid, palisaded or undefined subtypes. In some patients, several different histopathologic granulomatous patterns were found in the same biopsy. Some granulomas were associated with the presence of a vaccine strain of rubella virus. Cutaneous granulomas associated with a PID have a variable clinical presentation. A PID can be suspected when crusty, brownish lesions are found on the face or limbs. The concomitant presence of several histological subtypes in a single patient is suggestive of a PID.

Sections du résumé

BACKGROUND BACKGROUND
Paediatric cutaneous granuloma with primary immunodeficiency (PID) is a rare condition. The physiopathology is unclear, and treatment is challenging. We report on 17 paediatric cases and review the literature.
OBJECTIVES OBJECTIVE
To make dermatologists and dermatopathologists aware of the diagnostic value of skin granulomas in paediatric PID.
METHODS METHODS
We collected data on 17 patients with cutaneous granulomas and PID registered with us and also reviewed 33 cases from the literature.
RESULTS RESULTS
Cutaneous granuloma was the presenting feature of the PID in 15 of the 50 collated cases. The lesions presented as red-brownish nodules and infiltrated ulcerative plaques, predominantly on the face and limbs. Scleroderma-like infiltration on a single limb was observed in 10% of the cases. The associated PID was ataxia-telangiectasia (52%), combined immunodeficiency (24%), cartilage-hair hypoplasia (6%) and other subtypes (18%). The granulomas were mostly sarcoidal, tuberculoid, palisaded or undefined subtypes. In some patients, several different histopathologic granulomatous patterns were found in the same biopsy. Some granulomas were associated with the presence of a vaccine strain of rubella virus.
CONCLUSION CONCLUSIONS
Cutaneous granulomas associated with a PID have a variable clinical presentation. A PID can be suspected when crusty, brownish lesions are found on the face or limbs. The concomitant presence of several histological subtypes in a single patient is suggestive of a PID.

Identifiants

pubmed: 30869812
doi: 10.1111/jdv.15568
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1412-1420

Informations de copyright

© 2019 European Academy of Dermatology and Venereology.

Auteurs

S Leclerc-Mercier (S)

Department of Pathology, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (APHP), Paris, France.
National Reference Centre for Genodermatosis and Rare Diseases of the Skin (MAGEC), Necker-Enfants Malades Hospital, APHP, Paris, France.
Department of Dermatology, Necker-Enfants Malades Hospital, APHP, Paris, France.

D Moshous (D)

Department of Immunohematology, Necker-Enfants Malades Hospital, APHP, Paris, France.
Imagine Institute, Inserm U 1163, Descartes University, Paris Sorbonne Cité, Paris, France.

B Neven (B)

Department of Immunohematology, Necker-Enfants Malades Hospital, APHP, Paris, France.
Imagine Institute, Inserm U 1163, Descartes University, Paris Sorbonne Cité, Paris, France.

N Mahlaoui (N)

Department of Immunohematology, Necker-Enfants Malades Hospital, APHP, Paris, France.
National Reference Centre for Primary Immune Deficiency (CEREDIH), Necker-Enfants Malades Hospital, APHP, Paris, France.

L Martin (L)

Department of Dermatology, UNAM University, Angers University Hospital, Angers, France.

I Pellier (I)

Departments of Pediatric Hematology, UNAM University, Angers University Hospital, Angers, France.

S Blanche (S)

Department of Immunohematology, Necker-Enfants Malades Hospital, APHP, Paris, France.
Imagine Institute, Inserm U 1163, Descartes University, Paris Sorbonne Cité, Paris, France.
National Reference Centre for Primary Immune Deficiency (CEREDIH), Necker-Enfants Malades Hospital, APHP, Paris, France.

C Picard (C)

Department of Immunohematology, Necker-Enfants Malades Hospital, APHP, Paris, France.
Imagine Institute, Inserm U 1163, Descartes University, Paris Sorbonne Cité, Paris, France.
National Reference Centre for Primary Immune Deficiency (CEREDIH), Necker-Enfants Malades Hospital, APHP, Paris, France.
Study center of primary immunodeficiency, Necker-Enfants Malades Hospital, APHP, Paris, France.

A Fischer (A)

Department of Immunohematology, Necker-Enfants Malades Hospital, APHP, Paris, France.
Imagine Institute, Inserm U 1163, Descartes University, Paris Sorbonne Cité, Paris, France.
National Reference Centre for Primary Immune Deficiency (CEREDIH), Necker-Enfants Malades Hospital, APHP, Paris, France.
Collège de France, Paris, France.

P Perot (P)

Biology of Infection Unit, Institut Pasteur, Inserm U1117, Laboratory of Pathogen Discovery, Paris, France.

M Eloit (M)

Biology of Infection Unit, Institut Pasteur, Inserm U1117, Laboratory of Pathogen Discovery, Paris, France.
Ecole Nationale Vétérinaire d'Alfort, Virologie, Maisons Alfort, France.

S Fraitag (S)

Department of Pathology, Necker-Enfants Malades Hospital, Assistance Publique Hôpitaux de Paris (APHP), Paris, France.
National Reference Centre for Genodermatosis and Rare Diseases of the Skin (MAGEC), Necker-Enfants Malades Hospital, APHP, Paris, France.

C Bodemer (C)

National Reference Centre for Genodermatosis and Rare Diseases of the Skin (MAGEC), Necker-Enfants Malades Hospital, APHP, Paris, France.
Department of Dermatology, Necker-Enfants Malades Hospital, APHP, Paris, France.
Imagine Institute, Inserm U 1163, Descartes University, Paris Sorbonne Cité, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH